Anticancer Research: 42 (4)

April 2022; Volume 42,Issue 4

Reviews

Open Access
Intradural Cauda Equina Metastases: A Systematic Review of Clinico-radiological Features, Management, and Treatment Outcomes
PAOLO PALMISCIANO, SAIF E. ZAIDI, NATHAN A. SHLOBIN, NAVRAJ S. SAGOO, OTHMAN BIN ALAMER, GIANLUCA SCALIA, GIANLUCA FERINI, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER

Anticancer Research April 2022, 42 (4) 1661-1669; DOI: https://doi.org/10.21873/anticanres.15643
Open Access
Sun Exposure - Hazards and Benefits
PELLE G. LINDQVIST, ELISABETH EPSTEIN and MONA LANDIN-OLSSON

Anticancer Research April 2022, 42 (4) 1671-1677; DOI: https://doi.org/10.21873/anticanres.15644
Open Access
Accuracy of Serum Biomarker Panel (GastroPanel^®) in the Diagnosis of Atrophic Gastritis of the Corpus. Systematic Review and Meta-analysis
KARI SYRJÄNEN

Anticancer Research April 2022, 42 (4) 1679-1696; DOI: https://doi.org/10.21873/anticanres.15645

Experimental Studies

Open Access
Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth
JOSEPH L. LASKY, KATHRYN L. BRADFORD, YUNTAO WANG, YOUNGJU PAK and EDUARD H. PANOSYAN

Anticancer Research April 2022, 42 (4) 1697-1706; DOI: https://doi.org/10.21873/anticanres.15646
Open Access
Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells
AKIRA ISHIKAWA, KAZUYA KURAOKA, JUNICHI ZAITSU, AKIHISA SAITO, TOSHIO KUWAI, HIROFUMI TAZAWA, TAKAHISA SUZUKI, HIROTAKA TASHIRO, KIYOMI TANIYAMA and WATARU YASUI

Anticancer Research April 2022, 42 (4) 1707-1717; DOI: https://doi.org/10.21873/anticanres.15647
You have access
Adenovirus Vector With ADP Gene Induces Cytopathic Effects in HEK293 Cells Without Significant Elevation of Virus Titers
AOI SHIOTA, FUMITAKA NISHIMAE, FUMINORI SAKURAI and HIROYUKI MIZUGUCHI

Anticancer Research April 2022, 42 (4) 1719-1727; DOI: https://doi.org/10.21873/anticanres.15648
Open Access
Biological Differences Between Ovarian Cancer-associated Fibroblasts and Contralateral Normal Ovary-derived Mesenchymal Stem Cells
KAZUAKI OHASHI, TAO-SHENG LI, SHOKO MIURA, YURI HASEGAWA and KIYONORI MIURA

Anticancer Research April 2022, 42 (4) 1729-1737; DOI: https://doi.org/10.21873/anticanres.15649
You have access
Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer
SALEM ABOBAKER, HAGEN KULBE, ELIANE T. TAUBE, SILVIA DARB-ESFAHANI, ROLF RICHTER, CARSTEN DENKERT, PAUL JANK, JALID SEHOULI and ELENA IOANA BRAICU

Anticancer Research April 2022, 42 (4) 1739-1747; DOI: https://doi.org/10.21873/anticanres.15650
You have access
Association of Matrix Metallopeptidase-2 Genotypes With Risk of Gastric Cancer in Taiwan
CHUN-KAI FU, MEI-CHIN MONG, CHIEN-CHIH YU, MEI-DUE YANG, ZHI-HONG WANG, YA-CHEN YANG, JAW-CHYUN CHEN, JEN-SHENG PEI, NING-YI HSIA, CHIA-WEN TSAI, WEN-SHIN CHANG and DA-TIAN BAU

Anticancer Research April 2022, 42 (4) 1749-1755; DOI: https://doi.org/10.21873/anticanres.15651
You have access
TYRO3 Knockdown Suppresses the Growth of Myeloid Leukaemia Cells
TATSUYA SAITO, MAI ITOH and SHUJI TOHDA

Anticancer Research April 2022, 42 (4) 1757-1761; DOI: https://doi.org/10.21873/anticanres.15652
You have access
Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer
TAKASHI ASADA, SHINGO NAKAHATA, YANUAR RAHMAT FAUZI, TOMONAGA ICHIKAWA, KENTARO INOUE, NOBUHIRO SHIBATA, YOSHIRO FUJII, NAOYA IMAMURA, MASAHIDE HIYOSHI, ATSUSHI NANASHIMA and KAZUHIRO MORISHITA

Anticancer Research April 2022, 42 (4) 1763-1775; DOI: https://doi.org/10.21873/anticanres.15653
You have access
Relationship Between the Structure of Alkylpsoralens and Their Antiproliferative Activity in HL60 Cells
SATORU KAWAII, YU MATSUOKA, HIDEKI NOGUCHI, TAKANORI SATO and YUKO YOSHIZAWA

Anticancer Research April 2022, 42 (4) 1777-1783; DOI: https://doi.org/10.21873/anticanres.15654
You have access
Cytotoxic T Cells Activated by Self-differentiated Monocyte-derived Dendritic Cells Against Multiple Myeloma Cells
WANNASIRI CHIRAPHAPPHAIBOON, PIRIYA LUANGWATTANANUN, AUSSARA PANYA, NIPHAT JIRAPONGWATTANA, PRIMANA PUNNAKITIKASHEM, THAWEESAK CHIEOCHANSIN, MUTITA JUNKING and PA-THAI YENCHITSOMANUS

Anticancer Research April 2022, 42 (4) 1785-1799; DOI: https://doi.org/10.21873/anticanres.15655
You have access
Poly(Alkyloxyethylene-Lactate Phosphate) for Delivery of Doxorubicin: Synthesis and Characterization
KANJI YOSHIKAWA, TERUKI NII, KOLIO TROEV, KIMIKO MAKINO and ISSEI TAKEUCHI

Anticancer Research April 2022, 42 (4) 1801-1811; DOI: https://doi.org/10.21873/anticanres.15656
You have access
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer
JUN KI HONG, DO YEON KIM, JAE-SIK SHIN, YEA SEONG RYU, JAI-HEE MOON, DONG-IN KOH, SEUL LEE, JINWOO LEE, WON JUN LEE, EUN YOUNG LEE, SOO-A JUNG, SEUNG CHAN KIM, HA NA YU, MI JIN KIM, SEUNG-WOO HONG, SANG SOO PARK, JOONYEE JUNG, SEUNG MI KIM, EUN HO KIM, HONG-RAE JEONG, JI HEE GONG, JIEUN KIM, TAE WON KIM and DONG-HOON JIN

Anticancer Research April 2022, 42 (4) 1813-1819; DOI: https://doi.org/10.21873/anticanres.15657
You have access
Satraplatin Demonstrates High Cytotoxic Activity Against Genetically Defined Lymphoid Malignancies
THILO ZANDER, JIA XUE, GABRIEL MARKSON, FELIX DAHM and CHRISTOPH RENNER

Anticancer Research April 2022, 42 (4) 1821-1832; DOI: https://doi.org/10.21873/anticanres.15658
You have access
N-Trans-p-Coumaroyltyramine Enhances Indomethacin- and Diclofenac-induced Apoptosis Through Endoplasmic Reticulum Stress-dependent Mechanism in MCF-7 Cells
ANGKANA WONGSAKUL, NONTHALERT LERTNITIKUL, RUTT SUTTISRI and SUREE JIANMONGKOL

Anticancer Research April 2022, 42 (4) 1833-1844; DOI: https://doi.org/10.21873/anticanres.15659

Clinical Studies

Open Access
Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer
ZACHARY S. MAYO, EVELYN O. ILORI, BRIAN MATIA, TIMOTHY D. SMILE, CHRISTOPHER W. FLEMING, CHANDANA A. REDDY, JOSEPH SCHARPF, ERIC D. LAMARRE, BRANDON L. PRENDES, JAMIE KU, BRIAN B. BURKEY, NIKHIL P. JOSHI, NEIL M. WOODY, SHLOMO A. KOYFMAN and SHAUNA R. CAMPBELL

Anticancer Research April 2022, 42 (4) 1845-1849; DOI: https://doi.org/10.21873/anticanres.15660
Open Access
Hypofractionated Gamma Knife Radiosurgery: Institutional Experience on Benign and Malignant Intracranial Tumors
FRANCESCO INSERRA, FABIO BARONE, PAOLO PALMISCIANO, GIANLUCA SCALIA, VALERIO DA ROS, AHMED ABDELSALAM, ANTONIO CREA, MARIA GABRIELLA SABINI, SANTINO O. TOMASI, GIANLUCA FERINI, ROSARIO MAUGERI, LIDIA STRIGARI and GIUSEPPE EMMANUELE UMANA

Anticancer Research April 2022, 42 (4) 1851-1858; DOI: https://doi.org/10.21873/anticanres.15661
You have access
A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
AYA KATO, NORIKATSU MIYOSHI, TORU OHTSURU, DAISUKE SAKAI, JUNICHI HASEGAWA, KEN NAKATA, MITSUNOBU IMASATO, TAKESHI KATO, MASAKAZU IKENAGA, TOSHIHIRO KUDO, MITSUYOSHI TEI, YOSHINORI KAGAWA, MAMORU UEMURA, HIDEKAZU TAKAHASHI, TAROH SATOH, MASAKI MORI, TSUNEKAZU MIZUSHIMA, HIROFUMI YAMAMOTO, KOHEI MURATA, YUICHIRO DOKI and HIDETOSHI EGUCHI

Anticancer Research April 2022, 42 (4) 1859-1865; DOI: https://doi.org/10.21873/anticanres.15662
You have access
The Trend of Combined Modality Treatment and its Outcomes in Elderly Patients With Primary CNS Lymphoma: A 12-year Population-based Analysis Using Propensity Score
YAZAN SAMHOURI, MOAATH K. MUSTAFA ALI, CYRUS KHAN, RODNEY WEGNER, SEUNG TAE LEE and JOHN LISTER

Anticancer Research April 2022, 42 (4) 1867-1877; DOI: https://doi.org/10.21873/anticanres.15663
Open Access
The ColonView (CV) Quick Test for Fecal Occult Blood Shows Significantly Higher Diagnostic Accuracy in Detecting Distal than Proximal Colorectal Cancer
MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARÃES, TUOMAS SELANDER, TAPANI TIUSANEN, KARI SYRJÄNEN and MATTI ESKELINEN

Anticancer Research April 2022, 42 (4) 1879-1891; DOI: https://doi.org/10.21873/anticanres.15664
You have access
Clinical Utility and Cost of Postoperative Hemoglobin Level Testing Following Robotic-assisted Hysterectomy for Endometrial Cancer
MASSOUD SHORAKA, SEMIRAMIS L. CARBAJAL-MAMANI, BAHRAM DIDEBAN, ALI ZARRINPAR, CURTIS WARREN, BERNIE AMARO and JOEL CARDENAS-GOICOECHEA

Anticancer Research April 2022, 42 (4) 1893-1898; DOI: https://doi.org/10.21873/anticanres.15665
Open Access
Diabetes Mellitus and Oral Cancer: A Retrospective Study from Austria
BERNHARD REMSCHMIDT, MAURO PAU, JAN GAESSLER, WOLFGANG ZEMANN, NORBERT JAKSE, MICHAEL PAYER and DÁNIEL VÉGH

Anticancer Research April 2022, 42 (4) 1899-1903; DOI: https://doi.org/10.21873/anticanres.15666
Open Access
Clinical Outcomes of Ramucirumab as Post-treatment Following Atezolizumab/Bevacizumab Combination Therapy in Advanced Hepatocellular Carcinoma
TEIJI KUZUYA, NAOTO KAWABE, SENJU HASHIMOTO, KOHEI FUNASAKA, MITSUO NAGASAKA, YOSHIHITO NAKAGAWA, RYOJI MIYAHARA, TOMOYUKI SHIBATA, TAKESHI TAKAHARA, YUTARO KATO, ATSUSHI SUGIOKA and YOSHIKI HIROOKA

Anticancer Research April 2022, 42 (4) 1905-1910; DOI: https://doi.org/10.21873/anticanres.15667
You have access
Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy
MANUEL NEUBERGER, JANINA SKLADNY, NORA GOLY, FREDERIK WESSELS, CHRISTEL WEIß, LUISA EGEN, PHILIPP ERBEN, MATTHIAS GROß-WEEGE, BRITTA GRÜNE, FRIEDRICH HARTUNG, JONAS HERRMANN, PATRICK HONECK, JONAS JARCZYK, KARL-FRIEDRICH KOWALEWSKI, JULIA MÜHLBAUER, KATJA NITSCHKE, MALIN NIENTIEDT, MARGARETE THERESA WALACH, FRANK WALDBILLIG, NIKLAS WESTHOFF, JOST VON HARDENBERG, MAXIMILIAN KRIEGMAIR, THOMAS S. WORST and PHILIPP NUHN

Anticancer Research April 2022, 42 (4) 1911-1918; DOI: https://doi.org/10.21873/anticanres.15668
Open Access
Diagnostic Impact of Crypt Branching in Patients With Crohn’s Disease: A Validation Study
CORINNA LANG-SCHWARZ, CARLOS A. RUBIO and MICHAEL VIETH

Anticancer Research April 2022, 42 (4) 1919-1923; DOI: https://doi.org/10.21873/anticanres.15669
You have access
Improving Breast Conserving Surgery Using the Faxitron^® OR Specimen Radiography System – A Complication Analysis, Cost Evaluation and Literature Review
CHRISTIAN EICHLER, ANKE WESTERHOFF, MATHIAS WARM, BETTINA HANSTEIN, JULIAN PUPPE, BARBARA KRUG and WOLFRAM MALTER

Anticancer Research April 2022, 42 (4) 1925-1932; DOI: https://doi.org/10.21873/anticanres.15670
You have access
Oncogenic Fusions in Gliomas: An Institutional Experience
JIRI POLIVKA, MARIAN SVAJDLER, VLADIMIR PRIBAN, JAN MRACEK, PETR KASIK, PETR MARTINEK, NIKOLA PTAKOVA, MAHYAR SHARIF BAGHERI, DATTATRYA SHETTI, MARTIN PESTA, PAVEL POTUZNIK and ONDREJ TOPOLCAN

Anticancer Research April 2022, 42 (4) 1933-1939; DOI: https://doi.org/10.21873/anticanres.15671
You have access
A Real-world Multicenter Prospective Study of Everolimus in Pancreatic Neuroendocrine Tumors: The ‘PROTOR’ Study
GREGORY KALTSAS, CHARALAMBOS ANDREADIS, PARASKEVAS KOSMIDIS, DIMITRIOS MAVROUDIS, KALLIOPI PAZAITOU-PANAYIOTOU, MICHAIL VASLAMATZIS and ILIAS ATHANASIADIS

Anticancer Research April 2022, 42 (4) 1941-1948; DOI: https://doi.org/10.21873/anticanres.15672
You have access
Impact of Modern Management Strategies on the Clinical Outcome of Patients With Low Rectal Cancer – A Retrospective, Monocentric Cohort Study
ELIAS KARAM, REMY SINDAYIGAYA, URS GIGER-PABST, MICHEL GABRIEL, NICOLAS MICHOT, LISE COURTOT, NICOLAS TABCHOURI, DRIFFA MOUSSATA, THIERRY LECOMTE, SOPHIE CHAPET, GILLES CALAIS, PASCAL BOURLIER, EPHREM SALAMÉ and MEHDI OUAISSI

Anticancer Research April 2022, 42 (4) 1949-1963; DOI: https://doi.org/10.21873/anticanres.15673
You have access
Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma
CONCETTA LALISCIA, FEDERICA GENOVESI-EBERT, FRANCO PERRONE, FRANCESCA GUIDO, FEDERICA CRESTI, TAIUSHA FUENTES, NATALINA COCCIA, ROBERTO MATTIONI, RICCARDO MORGANTI and FABIOLA PAIAR

Anticancer Research April 2022, 42 (4) 1965-1972; DOI: https://doi.org/10.21873/anticanres.15674
You have access
Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer
DIRK RADES, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and ELISA M. WERNER

Anticancer Research April 2022, 42 (4) 1973-1977; DOI: https://doi.org/10.21873/anticanres.15675
You have access
Lactate Is a Reliable Predictor of ICU Length of Stay Following Ultra-radical Ovarian Cancer Surgery
SUSAN ADDLEY, MARK MCGOWAN, VIREN ASHER, ANISH BALI, SUMMI ABDUL, VICTORIA CULLIMORE, HARRIET CROSSLAND and ANDREW PHILLIPS

Anticancer Research April 2022, 42 (4) 1979-1986; DOI: https://doi.org/10.21873/anticanres.15676
You have access
Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?
MARTIN SVATON, MONIKA BRATOVA, LEONA KOUBKOVA, ONDREJ FISCHER, BOHUSLAV MELICHAR, MICHAL HRNCIARIK, DANIEL DOLEZAL, ONDREJ BILEK, JANA KREJCI, MARIE DROSSLEROVA, ZDENKA DLOUHA, JIRI BLAZEK, PETRA MAJKOVA, LUCIE BROZOVA and MAREK STASTNY

Anticancer Research April 2022, 42 (4) 1987-1995; DOI: https://doi.org/10.21873/anticanres.15677
You have access
Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases
KOICHI TOMITA, NAOKAZU CHIBA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TOSHIMICHI KOBAYASHI, TORU SANO, EIJI HIDAKA and SHIGEYUKI KAWACHI

Anticancer Research April 2022, 42 (4) 1997-2001; DOI: https://doi.org/10.21873/anticanres.15678
You have access
Differences in Patterns of Recurrence Between Primary and Interval Debulking Surgery for Advanced Ovarian Cancer
VASILEIOS MITSOPOULOS, ANNI INNAMAA, JONATHAN LIPPIATT, SARAH COLLINS and IOANNIS BILIATIS

Anticancer Research April 2022, 42 (4) 2003-2008; DOI: https://doi.org/10.21873/anticanres.15679
Open Access
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA

Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
You have access
Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study
ANGIOLO GADDUCCI, STEFANIA COSIO, FABIO LANDONI, ANDREA ALBERTO LISSONI, PAOLO ZOLA, MARIA ELENA LAUDANI, ANTONIO ARDIZZOIA, ANGELA GAMBINO and ENRICO SARTORI

Anticancer Research April 2022, 42 (4) 2017-2022; DOI: https://doi.org/10.21873/anticanres.15681
You have access
Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events
MICHIE KATSUTA, TAKAHIRO KIMURA, KOJIRO TASHIRO, MASAYA MURAKAMI, KENICHI HATA, TAKAFUMI YANAGISAWA, HAJIME ONUMA, TOSHIHIRO YAMAMOTO, SHINGO SUGAYA, YOSHINORI WATANABE, YOSHIMASA NOBEYAMA, SHIN EGAWA and AKIHIKO ASAHINA

Anticancer Research April 2022, 42 (4) 2023-2028; DOI: https://doi.org/10.21873/anticanres.15682
You have access
A Prognostic Tool to Estimate the Risk of Pneumonitis in Patients Irradiated for Lung Cancer
ESTHER GLATZEL, ELISA M. WERNER, SABINE BOHNET and DIRK RADES

Anticancer Research April 2022, 42 (4) 2029-2032; DOI: https://doi.org/10.21873/anticanres.15683
You have access
CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA and SOICHIRO ISHIHARA

Anticancer Research April 2022, 42 (4) 2033-2043; DOI: https://doi.org/10.21873/anticanres.15684
You have access
Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA

Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
You have access
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI and ICHIRO IEIRI

Anticancer Research April 2022, 42 (4) 2053-2060; DOI: https://doi.org/10.21873/anticanres.15686
You have access
The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma
SHOHEI TSUTSUMI, KAHO MOMIYAMA, MASAAKI ICHINOE, TAKUYA KATO, SACHIYO MOGI, SHUNSUKE MIYAMOTO, YOSHIKI MURAKUMO and TAKU YAMASHITA

Anticancer Research April 2022, 42 (4) 2061-2070; DOI: https://doi.org/10.21873/anticanres.15687
You have access
Elevated Preoperative DUPAN-2 Level Predicts Locoregional Recurrence After Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma
ATSUSHI SASAKI, SHOICHI INOKUCHI, SATOSHI TSUTSUMI, TAKURO FUTSUKAICHI, TAKAHIRO TERASHI, MASAHIKO IKEBE, TOSHIO BANDOH and TOHRU UTSUNOMIYA

Anticancer Research April 2022, 42 (4) 2071-2078; DOI: https://doi.org/10.21873/anticanres.15688
You have access
Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence
MASUMI TANAKA, SHIN-ICHI YAMASHITA, YASUTERU YOSHINAGA, YASUKO ENOMOTO, YUKI NOHARA, SYUKO ONO, KAZUKI NABESHIMA, AKINORI IWASAKI and TOSHIHIKO SATO

Anticancer Research April 2022, 42 (4) 2079-2085; DOI: https://doi.org/10.21873/anticanres.15689
You have access
Combined Use of Calcium-channel Blockers With Ombitasvir/Paritaprevir/Ritonavir Exacerbates Peripheral Edema in Elderly Japanese Patients
YUNA SADAKA, MIDORI SODA, AKIYO HORI, YURI MIYAHARA, YASUHISA OIDA, YOICHI NISHIGAKI, EIICHI TOMITA, TAKASHI MIZUI and KIYOYUKI KITAICHI

Anticancer Research April 2022, 42 (4) 2087-2093; DOI: https://doi.org/10.21873/anticanres.15690
Open Access
Clinical Outcomes of Radiotherapy in Elderly and Younger Patients With T4 Esophageal Cancer: A Retrospective Single-center Analysis
YOSUKE TAKAKUSAGI, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, HIROYUKI KATOH, TADASHI KAMADA, RISA TANIUCHI, MISAKI IINO, TOMOMI AOSHIKA, SATOSHI SAITO and DAISAKU YOSHIDA

Anticancer Research April 2022, 42 (4) 2095-2104; DOI: https://doi.org/10.21873/anticanres.15691
You have access
Influence of the Coronavirus Disease 2019 Vaccine on Drug Therapy for Urological Cancer
SHOHEI KAWAGUCHI, KOUJI IZUMI, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, MASASHI IIJIMA, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research April 2022, 42 (4) 2105-2111; DOI: https://doi.org/10.21873/anticanres.15692
You have access
Predictors of Lateral Pelvic Lymph Node Metastasis in Advanced Low Rectal Cancer Treated With Neoadjuvant Chemotherapy
TETSUO ISHIZAKI, KENJI KATSUMATA, MASANOBU ENOMOTO, JUNICHI MAZAKI, RYUTARO UDO, TOMOYA TAGO, KENTA KASAHARA, HIROSHI KUWABARA, YUICHI NAGAKAWA and AKIHIKO TSUCHIDA

Anticancer Research April 2022, 42 (4) 2113-2121; DOI: https://doi.org/10.21873/anticanres.15693
You have access
Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy
MOTOHIRO FUJIWARA, RYO FUJIWARA, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA

Anticancer Research April 2022, 42 (4) 2123-2130; DOI: https://doi.org/10.21873/anticanres.15694
You have access
Significance of Altered Fatty Acid Transporter Expressions in Uterine Cervical Cancer and Its Precursor Lesions
JUNGSUK AN, HWA EUN OH, HYESUN KIM, JU-HAN LEE, EUNG SEOK LEE, YOUNG-SIK KIM and JUNG-WOO CHOI

Anticancer Research April 2022, 42 (4) 2131-2137; DOI: https://doi.org/10.21873/anticanres.15695
You have access
Clavicula Pro Humero Reconstruction for Malignant Tumor of the Proximal Humerus in Children and Adults
HIDEYUKI KINOSHITA, HIROTO KAMODA, YOKO HAGIWARA, TAKESHI ISHII, SEIJI OHTORI and TSUKASA YONEMOTO

Anticancer Research April 2022, 42 (4) 2139-2144; DOI: https://doi.org/10.21873/anticanres.15696
You have access
Real-world Afatinib Outcomes in Advanced Non–small Cell Lung Cancer Harboring EGFR Mutations
CHI-HAN CHEN, JOHN WEN-CHENG CHANG, CHING-FU CHANG, CHEN-YANG HUANG, CHENG-TA YANG, CHIH-HSI SCOTT KUO, YUEH-FU FANG, PING-CHIH HSU and CHIAO-EN WU

Anticancer Research April 2022, 42 (4) 2145-2157; DOI: https://doi.org/10.21873/anticanres.15697
You have access
Additional Excision Biopsy in Patients With Atypical Ductal Hyperplasia at Ultrasound-guided Vacuum-assisted Breast Biopsy
HAI LIN PARK, BORA YANG, JI EUN SHIN, JI-YOUNG KIM, JEONG YUN SHIN, EUNAH SHIN, SONGMI NOH and JAE HONG KIM

Anticancer Research April 2022, 42 (4) 2159-2165; DOI: https://doi.org/10.21873/anticanres.15698
You have access
Treatment Outcomes in Neuroendocrine Prostate Cancer
HIROAKI IWAMOTO, RYUNOSUKE NAKAGAWA, TOMOYUKI MAKINO, SUGURU KADOMOTO, HIROSHI YAEGASHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research April 2022, 42 (4) 2167-2176; DOI: https://doi.org/10.21873/anticanres.15699
You have access
The Significance of Surgical Intervention for Metasynchronous Liver Metastasis in Gastric Cancer: A Single-centre Analysis
TAKEHIKO HANAKI, TEPPEI SUNAGUCHI, KEISUKE GOTO, MASAKI MORIMOTO, YUKI MURAKAMI, YUJI SHISHIDO, KOZO MIYATANI, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, MANABU YAMAMOTO, NARUO TOKUYASU, TERUHISA SAKAMOTO, TOSHIMICHI HASEGAWA and YOSHIYUKI FUJIWARA

Anticancer Research April 2022, 42 (4) 2177-2184; DOI: https://doi.org/10.21873/anticanres.15700
You have access
Tumor Size Significantly Affects Prognosis in Pathological T3a Renal Cell Carcinoma
GU-SHUN LAI, JIAN-RI LI, SHIAN-SHIANG WANG, CHUAN-SHU CHEN, CHUN-KUANG YANG, SHENG-CHUN HUNG, CHEN-LI CHENG, YEN-CHUAN OU and KUN-YUAN CHIU

Anticancer Research April 2022, 42 (4) 2185-2191; DOI: https://doi.org/10.21873/anticanres.15701

ABSTRACTS OF THE JOINT INTERNATIONAL SYMPOSIA “VITAMIN D IN PREVENTION AND THERAPY” AND “BIOLOGIC EFFECTS OF LIGHT”

You have access
ABSTRACTS OF THE JOINT INTERNATIONAL SYMPOSIA “VITAMIN D IN PREVENTION AND THERAPY” AND “BIOLOGIC EFFECTS OF LIGHT”
J. REICHRATH, TH. VOGT, M.F. HOLICK and M. FRIEDRICH

Anticancer Research April 2022, 42 (4) 2193-2222; DOI: https://doi.org/10.21873/anticanres.15702

Corrigendum

You have access
Corrigendum
Anticancer Research April 2022, 42 (4) 2223;

Main menu

User menu

Search

Table of Contents

Reviews

Experimental Studies

Clinical Studies

ABSTRACTS OF THE JOINT INTERNATIONAL SYMPOSIA “VITAMIN D IN PREVENTION AND THERAPY” AND “BIOLOGIC EFFECTS OF LIGHT”

Corrigendum

In this issue

Issue highlights

Jump to